Correction to: Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside (Molecular Neurobiology, (2022), 59, 1, (657-680), 10.1007/s12035-021-02617-1)

Vaibhav Walia; Deepak Kaushik; Vineet Mittal; Kuldeep Kumar; Ravinder Verma; Jatin Parashar; Rokeya Akter; Md Habibur Rahman; Saurabh Bhatia; Ahmed Al-Harrasi; Chenmala Karthika; Tanima Bhattacharya; Hitesh Chopra; Ghulam Md Ashraf

doi:10.1007/s12035-021-02665-7

Correction to: Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside (Molecular Neurobiology, (2022), 59, 1, (657-680), 10.1007/s12035-021-02617-1)

Vaibhav Walia
, Deepak Kaushik^*
, Vineet Mittal
, Kuldeep Kumar
, Ravinder Verma
, Jatin Parashar
, Rokeya Akter
, Md Habibur Rahman^*
, Saurabh Bhatia
, Ahmed Al-Harrasi
, Chenmala Karthika
, Tanima Bhattacharya
, Hitesh Chopra
, Ghulam Md Ashraf

^*Corresponding author for this work

Shree Guru Gobind Singh Tricentenary University
Maharshi Dayanand University
Punjabi University
Institute of Nano Science and Technology
GD Goenka University
Jagannath University
Southeast University, Dhaka
University of Petroleum and Energy Studies
University of Nizwa
JSS Academy of Higher Education & Research
Hubei University
Chitkara University
Pre-Clinical Research Unit
King Abdulaziz University
Department of Medical Laboratory Technology

Research output: Contribution to journal › Comment/debate

Abstract

The original version of this article unfortunately assigned an incorrect affiliation to the three authors namely Vineet Mittal, Jatin Parashar and Deepak Kaushik. They should be affiliated to Department of Pharmaceutical Sciences, M.D. University, Rohtak, 124001, India. With this, the original article was corrected.

Original language	English
Pages (from-to)	681-682
Number of pages	2
Journal	Molecular Neurobiology
Volume	59
Issue number	1
DOIs	https://doi.org/10.1007/s12035-021-02665-7
Publication status	Published - Jan 2022
Externally published	Yes

Access to Document

10.1007/s12035-021-02665-7

Fingerprint

Dive into the research topics of 'Correction to: Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside (Molecular Neurobiology, (2022), 59, 1, (657-680), 10.1007/s12035-021-02617-1)'. Together they form a unique fingerprint.

Cite this

Walia, V., Kaushik, D., Mittal, V., Kumar, K., Verma, R., Parashar, J., Akter, R., Rahman, M. H., Bhatia, S., Al-Harrasi, A., Karthika, C., Bhattacharya, T., Chopra, H., & Ashraf, G. M. (2022). Correction to: Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside (Molecular Neurobiology, (2022), 59, 1, (657-680), 10.1007/s12035-021-02617-1). Molecular Neurobiology, 59(1), 681-682. https://doi.org/10.1007/s12035-021-02665-7

Walia, Vaibhav ; Kaushik, Deepak ; Mittal, Vineet et al. / Correction to : Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside (Molecular Neurobiology, (2022), 59, 1, (657-680), 10.1007/s12035-021-02617-1). In: Molecular Neurobiology. 2022 ; Vol. 59, No. 1. pp. 681-682.

@article{4f59e8750226455389c90aaf76143cf5,

title = "Correction to: Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer{\textquoteright}s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside (Molecular Neurobiology, (2022), 59, 1, (657-680), 10.1007/s12035-021-02617-1)",

abstract = "The original version of this article unfortunately assigned an incorrect affiliation to the three authors namely Vineet Mittal, Jatin Parashar and Deepak Kaushik. They should be affiliated to Department of Pharmaceutical Sciences, M.D. University, Rohtak, 124001, India. With this, the original article was corrected.",

author = "Vaibhav Walia and Deepak Kaushik and Vineet Mittal and Kuldeep Kumar and Ravinder Verma and Jatin Parashar and Rokeya Akter and Rahman, \{Md Habibur\} and Saurabh Bhatia and Ahmed Al-Harrasi and Chenmala Karthika and Tanima Bhattacharya and Hitesh Chopra and Ashraf, \{Ghulam Md\}",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media, LLC, part of Springer Nature 2021.",

year = "2022",

month = jan,

doi = "10.1007/s12035-021-02665-7",

language = "English",

volume = "59",

pages = "681--682",

journal = "Molecular Neurobiology",

issn = "0893-7648",

number = "1",

}

Walia, V, Kaushik, D, Mittal, V, Kumar, K, Verma, R, Parashar, J, Akter, R, Rahman, MH, Bhatia, S, Al-Harrasi, A, Karthika, C, Bhattacharya, T, Chopra, H & Ashraf, GM 2022, 'Correction to: Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside (Molecular Neurobiology, (2022), 59, 1, (657-680), 10.1007/s12035-021-02617-1)', Molecular Neurobiology, vol. 59, no. 1, pp. 681-682. https://doi.org/10.1007/s12035-021-02665-7

Correction to: Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside (Molecular Neurobiology, (2022), 59, 1, (657-680), 10.1007/s12035-021-02617-1). / Walia, Vaibhav; Kaushik, Deepak; Mittal, Vineet et al.
In: Molecular Neurobiology, Vol. 59, No. 1, 01.2022, p. 681-682.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside (Molecular Neurobiology, (2022), 59, 1, (657-680), 10.1007/s12035-021-02617-1)

AU - Walia, Vaibhav

AU - Kaushik, Deepak

AU - Mittal, Vineet

AU - Kumar, Kuldeep

AU - Verma, Ravinder

AU - Parashar, Jatin

AU - Akter, Rokeya

AU - Rahman, Md Habibur

AU - Bhatia, Saurabh

AU - Al-Harrasi, Ahmed

AU - Karthika, Chenmala

AU - Bhattacharya, Tanima

AU - Chopra, Hitesh

AU - Ashraf, Ghulam Md

PY - 2022/1

Y1 - 2022/1

N2 - The original version of this article unfortunately assigned an incorrect affiliation to the three authors namely Vineet Mittal, Jatin Parashar and Deepak Kaushik. They should be affiliated to Department of Pharmaceutical Sciences, M.D. University, Rohtak, 124001, India. With this, the original article was corrected.

AB - The original version of this article unfortunately assigned an incorrect affiliation to the three authors namely Vineet Mittal, Jatin Parashar and Deepak Kaushik. They should be affiliated to Department of Pharmaceutical Sciences, M.D. University, Rohtak, 124001, India. With this, the original article was corrected.

UR - https://www.scopus.com/pages/publications/85120067290

U2 - 10.1007/s12035-021-02665-7

DO - 10.1007/s12035-021-02665-7

M3 - Comment/debate

C2 - 34839460

AN - SCOPUS:85120067290

SN - 0893-7648

VL - 59

SP - 681

EP - 682

JO - Molecular Neurobiology

JF - Molecular Neurobiology

IS - 1

ER -

Walia V, Kaushik D, Mittal V, Kumar K, Verma R, Parashar J et al. Correction to: Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside (Molecular Neurobiology, (2022), 59, 1, (657-680), 10.1007/s12035-021-02617-1). Molecular Neurobiology. 2022 Jan;59(1):681-682. doi: 10.1007/s12035-021-02665-7

Correction to: Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside (Molecular Neurobiology, (2022), 59, 1, (657-680), 10.1007/s12035-021-02617-1)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this